Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination

被引:115
作者
Rideout, HJ
Stefanis, L
机构
[1] Columbia Univ, Dept Neurol, New York, NY 10032 USA
[2] Columbia Univ, Dept Pathol, New York, NY 10032 USA
关键词
D O I
10.1006/mcne.2002.1173
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Increasing evidence suggests that proteasomal dysfunction plays a role in the pathogenesis of Lewy body diseases. We have used pharmacological inhibitors of the proteasome to model proteasomal dysfunction in cultured rat cortical neurons. Proteasomal inhibition induce apoptotic death and formation of cytoplasmic ubiquitinated inclusions, which were present only in viable neurons. Actinomycin D, but not a caspase inhibitor, prevented inclusion formation, whereas both agents inhibited cell death. alpha-Synuclein and thioflavin S staining were found within the inclusions. alpha-Synuclein, however, did not appear to be ubiquitinated or aggregated. A dominant-negative mutant of an E2 ubiquitin-conjugating enzyme, cdc34, prevented inclusion formation and attenuate cell death. Our results suggest that in cortical neurons: (a) proteasomal dysfunction plays a role in formation of ubiquitin/alpha-synuclein-positive inclusions, (b) inclusion formation is an active cell process requiring transcription, and (c) ubiquitination of certain proteins is required for inclusion formation and may participate in neuronal death.
引用
收藏
页码:223 / 238
页数:16
相关论文
共 76 条
[1]   Ubiquitin, cellular inclusions and their role in neurodegeneration [J].
Alves-Rodrigues, A ;
Gregori, L ;
Figueiredo-Pereira, ME .
TRENDS IN NEUROSCIENCES, 1998, 21 (12) :516-520
[2]   α-Synuclein and the Parkinson's disease-related mutant Ala53Thr-α-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells [J].
Ancolio, K ;
da Costa, CA ;
Uéda, K ;
Checler, F .
NEUROSCIENCE LETTERS, 2000, 285 (02) :79-82
[3]   Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease [J].
Auluck, PK ;
Chan, HYE ;
Trojanowski, JQ ;
Lee, VMY ;
Bonini, NM .
SCIENCE, 2002, 295 (5556) :865-868
[4]  
Baba M, 1998, AM J PATHOL, V152, P879
[5]   CHARACTERIZATION OF A DOMINANT-NEGATIVE MUTANT OF THE CELL-CYCLE UBIQUITIN-CONJUGATING ENZYME CDC34 [J].
BANERJEE, A ;
DESHAIES, RJ ;
CHAU, V .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (44) :26209-26215
[6]   Impairment of the ubiquitin-proteasome system by protein aggregation [J].
Bence, NF ;
Sampat, RM ;
Kopito, RR .
SCIENCE, 2001, 292 (5521) :1552-1555
[7]   Degradation of α-synuclein by proteasome [J].
Bennett, MC ;
Bishop, JF ;
Leng, Y ;
Chock, PB ;
Chase, TN ;
Mouradian, MM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (48) :33855-33858
[8]  
Cappelletti G, 1999, J NEUROSCI RES, V56, P28, DOI 10.1002/(SICI)1097-4547(19990401)56:1<28::AID-JNR4>3.0.CO
[9]  
2-2
[10]  
CHAIN DG, 1995, J NEUROSCI, V15, P7592